MICHELLE HASSARD: Open Payments
NPI 1558023903 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 19 payments from 14 companies in 2025. Trend: 2023 $530 · 2024 $888 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $43 |
| Gilead Sciences, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: REXULTI, MOUNJARO, Cologuard Collection Kit, QULIPTA, Auvelity, Ozempic, TREMFYA, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
